Induction of Cytokines in Human Monocytes by SARS-CoV in Adults and Children
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Severe acute respiratory syndrome (SARS) is a new emerging infectious disease. Its pathogen is a newly discovered coronavirus (SARS-CoV). The clinical course can be classified to 3 stages: viral replication phase, hyperimmune reactive phase, and pulmonary destruction phase. Human monocyte plays a critical role in the initiation of immune response in defending the intracellular pathogens (eg viruses). Monocytes can engulf viruses and present the viral antigens in the major histocompatibility (MHC) molecule to the cell surface to initiate T lymphocyte response. Monocytes also secrete various cytokines to modulate immune response. SARS-CoV is a mutant of animal virus to cause human disease and is able to cause unusual severe respiratory illness. It is suggested the unusual severe disease is due to the intense immune reaction.
The investigators will harvest human monocytes from healthy adult and children blood donors. Monocytes would be cultured and infected by SARS-CoV. The change of viral load is monitored after infection. Cytokines secreted by monocytes after infection are also measured. The difference of monocyte cytokine secretion is compared between adults and children. The study is to verify the SARS-CoV infectivity of human monocytes and prove the unusual severity caused by SARS-CoV is related to viral-induced dysregulation of cytokine responses. The results may also clarify why adults tend to have a more severe illness compared with children.
| Condition |
|---|
|
Healthy |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Induction of Cytokines in Human Monocytes by SARS-CoV in Adults and Children |
Eligibility| Ages Eligible for Study: | 2 Years to 50 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Healthy adults aged 20 to 50 years old
- Healthy children aged 2 to 5 years old
Contacts and Locations| Taiwan | |
| National Taiwan University Hospital | Recruiting |
| Taipei, Taiwan, 100 | |
| Contact: Luan-Yin Chang, MD, PhD 886-2-23123456 ext 3245 Ly7077@tpts6.seed.net.tw | |
| Contact: Pei-Lan Shao, MD 886-2-23123456 ext 2394 shaopl@ha.mc.ntu.edu.tw | |
| Principal Investigator: | Luan-Yin Chang, MD, PhD | Department of pediatrics, National Taiwan University Hospital |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00173563 History of Changes |
| Other Study ID Numbers: | 9461700731, NSC92-2751-B-002-026-Y |
| Study First Received: | September 12, 2005 |
| Last Updated: | November 30, 2007 |
| Health Authority: | Taiwan: Department of Health |
Keywords provided by National Taiwan University Hospital:
|
Immunology |
ClinicalTrials.gov processed this record on June 13, 2013